about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
3.16
0.11
(3.61%)
4.4M
XNAS Volume
XNAS 22 Sep, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..